CINB + Medical Therapy for Rib Fractures
Trial Summary
What is the purpose of this trial?
This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures. The objective of this study is to analyze the effect of continuous intercostal nerve block (CINB) in the treatment of patients admitted to the adult trauma service with rib fractures. The effectiveness of CINB as adjunctive treatment will be compared to standard medical therapy involving nonsteroidal and intravenous/oral opioid medications.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications. It involves adding a new treatment (CINB) to standard medical care, which includes non-steroidal and opioid medications.
What data supports the effectiveness of the drug CINB + Medical Therapy for Rib Fractures?
Is the treatment CINB + Medical Therapy for Rib Fractures safe for humans?
Nonsteroidal anti-inflammatory drugs (NSAIDs) like ketorolac and ropivacaine (Naropin) are generally used for pain relief, but they can have side effects such as increased bleeding risk and potential impact on bone healing. These risks are often dose-related and more common with prolonged use, so they need to be carefully assessed for each individual.678910
How does the CINB + Medical Therapy treatment for rib fractures differ from other treatments?
The CINB (continuous intercostal nerve block) combined with medical therapy, including non-steroidal anti-inflammatory drugs and opioids, offers a unique approach by providing targeted pain relief directly to the nerves near the ribs, potentially reducing the need for systemic narcotics and minimizing side effects compared to traditional methods like epidural analgesia.411121314
Research Team
Zachary Warriner, MD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for adults over 18 with multiple rib fractures who agree to try a pain treatment involving nerve blocks. They must be willing to give informed consent. People can't join if they refuse the nerve block therapy, are allergic to the medication used in the study, already use an epidural catheter, or are prisoners.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive continuous intercostal nerve block (CINB) plus medical therapy or standard medical care for rib fractures
Follow-up
Participants are monitored for safety and effectiveness after treatment, including outpatient follow-up
Treatment Details
Interventions
- Non steroidal anti-inflammatory drug and opioids (Analgesic)
- Ropivacaine (Local Anesthetic)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zachary Warriner
Lead Sponsor